However, the TILs of removed tissues and post-surgery PBMCs from the 6-month relapse HCC patients showed a notably higher Treg/Tef ratio, while the HCC patients without relapse within 6 months exhibited a lower Treg/Tef ratio (Fig. 6d). The gene discussed is TEF; the disease is hepatocellular carcinoma.